期刊文献+

应用p75^NTR分选食管肿瘤干细胞并鉴定其生物学特性 被引量:13

p75^(NTR) in isolation and identification of cancer stem cells from human esophageal carcinoma
下载PDF
导出
摘要 目的:应用p75NTR进行人食管肿瘤干细胞的分选,并对其生物学特性进行鉴定。方法:对人食管癌标本癌细胞及食管癌细胞株TE-1、Eca109进行培养,应用流式细胞仪检测p75NTR在人食管癌细胞(esophageal cancer cells,ECCs)中的表达,应用磁珠分选(MACS)法进行p75NTR阳性细胞与阴性细胞的分选,观察p75NTR阳性细胞的增殖、分化及软琼脂克隆形成能力,并进行裸鼠接种以观察其致瘤能力;应用化疗药物作用于ECCs后检测其中p75NTR阳性细胞与阴性细胞存活率,以评价p75NTR阳性细胞对化疗药物的耐受性。结果:8个食管肿瘤细胞系(株)中,除SHEC-1、SHEC-5未检测到p75NTR阳性细胞外,其余6个细胞系(株)SHEC-4、SHEC-6、SHEC-7、SHEC-8、Eca109、TE-1中均检测到p75NTR阳性细胞,阳性细胞比例分别为2.71%、0.32%、3.35%、1.13%、2.15%、0.45%。与阴性及未分选细胞相比,MACS分选后的p75NTR阳性细胞具有较强的增殖能力,具有分化产生其他表型细胞的能力,在软琼脂中具有较强的克隆形成能力(P<0.01);行裸鼠接种时,p75NTR阳性细胞表现出较强的致瘤性,其中SHEC-7细胞只需2×103个即可致瘤,其致瘤能力是未分选细胞的50倍。化疗药物分别作用于p75NTR阳性细胞与阴性细胞48h后,p75NTR阳性细胞的存活比例明显高于阴性细胞(P<0.05)。结论:人食管肿瘤细胞中p75NTR阳性细胞具有自我更新、分化、增殖能力,对化疗药物具有较强的耐受性,并具有较强的致瘤能力,具有肿瘤干细胞的特性。 Objective: To isolate and identify cancer stem cells from esophageal cancer cells (ECCs) using cell surface marker p75^NTR. Methods: ECCs were cultured from surgically resected ECC specimens; ECC cell lines TE-1 and Eca109 were also cultured. The expression of p75^NTR in human ECCs was examined by flow cytometry, p75^NTR positive cells were isolated from ECCs using magnetic activated cell sorting (MACS) method. The proliferation,differentiation,and the ability of colony-forming in soft agar of the p75^NTR positive cells were observed. The p75^NTR positive cells were injected into BALB/c nude mice subcutaneously to observe their tumorigenesis ability. The survival rates of p75^NTRpositive and negative cells were assessed after treated with chemotherapy drugs to evaluate the resistance of p75^NTR positive cells. Results: Six out of the eight cell lines, including SHEC-4, SHEC-6, SHEC-7, SHEC-8, Eeal09, and TE-1, were positive of p75^NTR , with the positive rates being 2.71%, 0.32% , 3.35% , 1.13% , 2.15%, and 0.45%, respectively. It was showed that p75^NTR positive cells possessed higher proliferation ability compared with p75^NTR negative cells (P〈0.01). The p75^NTR positive cells had higher colony-forming ability in soft agar compared with p75^NTR negative cells (P〈0.01). The p75^NTR positive cells demonstrated stronger tumorigenesis ability in nude mice. As few as 2 000 SHEC-7 cells could give rise to new tumors in xenotransplantation,with a tumorigenesis ability 50 times as high as that of the p75^NTR negative cells. When treated with chemotherapy drugs for 48 h,p75^NTRpositive cells had significantly higher survival rate than p75^NTR negative cells (P〈 0. 05 ). Conclusion: The p75^NTR positive ECCs possess self-renewal, differentiation,and proliferation abilities; they are strongly resistant to chemotherapy drugs, which gives them strong tumorigenesis ability and the characters of tumor stem cells.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2009年第5期481-486,共6页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(30471718)~~
关键词 食管肿瘤 肿瘤干细胞 P75^NTR 细胞分选 致癌性试验 肿瘤抗药性 esophageal neoplasms tumor stem cells p75^NTR cell storing tumorigenecity test neoplasm drug resistance
  • 相关文献

参考文献21

  • 1Reya T,Morrison S J,Clarke M F,Weissman I L.Stem cells,cancer,and cancer stem cells[J].Nature,414:105-111. 被引量:1
  • 2Bonnet D,Dick J E.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3:730-737. 被引量:1
  • 3Lapidot T,Sirard C,Vormoor J,Murdoch B,Hoang T,Caceres-Cortes J,et al.A cell initiating human acute myeloid leukaemia after transplantation into SCID mice[J].Nature,1994,367:645-648. 被引量:1
  • 4Ponti D,Costa A,Zaffaroni N,Pratesi G,Petrangolini G,Coradini D,et al.Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties[J].Cancer Res,2005,65:5506-5511. 被引量:1
  • 5Al-Hajj M,Wicha M S,Benito-Hernandez A,Morrison S J,Clarke M F.Prospective identification of tumorigenic breast cancer cells[J].Proc Natl Acad Sci USA,2003,100:3983-3988. 被引量:1
  • 6Singh S K,Hawkins C,Clarke I D,Squire J A,Bayani J,Hide T,et al.Identification of human brain tumour initiating cells[J].Nature,2004,432:396-401. 被引量:1
  • 7Singh S K,Clarke I D,Terasaki M,Bonn V E,Hawkins C,Squire J,et al.Identification of a cancer stem cell in human brain tumors[J].Cancer Res,2003,63:5821-5828. 被引量:1
  • 8Patrawala L,Calhoun T,Schneider-Broussard R,Li H,Bhatia B,Tang S,et al.Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells[J].Oncogene,2006,25:1696-1708. 被引量:1
  • 9Collins A T,Berry P A,Hyde C,Stower M J,Maitland N J.Prospective identification of tumorigenic prostate cancer stem cells[J].Cancer Res,2005,65:10946-10951. 被引量:1
  • 10Kim C F,Jackson E L,Woolfenden A E,Lawrence S,Babar I,Vogel S,et al.Identification of bronchioalveolar stem cells in normal lung and lung cancer[J].Cell,2005,121:823-835. 被引量:1

同被引文献214

引证文献13

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部